146 related articles for article (PubMed ID: 8216445)
1. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.
Sakashita M; Yamaguchi T; Miyazaki H; Sekine Y; Nomiyama T; Tanaka S; Miwa T; Harasawa S
Arzneimittelforschung; 1993 Aug; 43(8):867-72. PubMed ID: 8216445
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
Sakashita M; Mizuki Y; Yamaguchi T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats.
Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats.
Matsumoto S; Tagawa M; Hatoyama T; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study.
Keller GA; Czerniuk P; Bertuola R; de Mena F; Simoni MV; Assefi AR; Di Girolamo G
Curr Med Res Opin; 2011 Nov; 27(11):2203-11. PubMed ID: 21970660
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the gastroprokinetic agent mosapride citrate after single oral administration in horses.
Okamura K; Sasaki N; Fukunaka M; Yamada H; Inokuma H
J Vet Med Sci; 2010 Aug; 72(8):1023-6. PubMed ID: 20467210
[TBL] [Abstract][Full Text] [Related]
10. [Determination of mosapride in human plasma by high performance liquid chromatography tandem mass spectrometry].
Qin F; Chen LY; Ma YY; Wang D; Liu J; Lu XM; Li FM
Yao Xue Xue Bao; 2007 Aug; 42(8):882-5. PubMed ID: 17944240
[TBL] [Abstract][Full Text] [Related]
11. Effects of food intake on pharmacokinetics of mosapride in beagle dogs.
Chae JW; Song BJ; Baek IH; Yun HY; Ma JY; Kwon KI
J Vet Pharmacol Ther; 2015 Oct; 38(5):497-9. PubMed ID: 25622855
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of reboxetine in healthy volunteers. Single against repeated oral doses and lack of enzymatic alterations.
Pellizzoni C; Poggesi I; Jørgensen NP; Edwards DM; Paus E; Strolin Benedetti M
Biopharm Drug Dispos; 1996 Oct; 17(7):623-33. PubMed ID: 8894119
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of brodimoprim.
Weidekamm E
J Chemother; 1993 Dec; 5(6):475-9. PubMed ID: 8195840
[TBL] [Abstract][Full Text] [Related]
15. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS.
Sun X; Niu L; Li X; Lu X; Li F
J Pharm Biomed Anal; 2009 Aug; 50(1):27-34. PubMed ID: 19362796
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of clofazimine in healthy volunteers.
Schaad-Lanyi Z; Dieterle W; Dubois JP; Theobald W; Vischer W
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):9-15. PubMed ID: 3559339
[TBL] [Abstract][Full Text] [Related]
17. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
Yoshida N; Omoya H; Kato S; Ito T
Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
[TBL] [Abstract][Full Text] [Related]
19. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin.
Itoh H; Nagano T; Takeyama M
Biol Pharm Bull; 2001 Sep; 24(9):1072-5. PubMed ID: 11558572
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
